These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6817454)

  • 1. Studies on a form of alpha 2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen.
    Wiman B; Nilsson T; Cedergren B
    Thromb Res; 1982 Oct; 28(2):193-9. PubMed ID: 6817454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two forms of alpha 2-antiplasmin: differences in KAV and isoelectric point.
    Högstorp H; Jacobsson H; Wallin R; Saldeen T
    Thromb Res; 1984 Sep; 35(5):559-65. PubMed ID: 6484898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII.
    Kluft C; Los P; Jie AF
    Thromb Res; 1984 Feb; 33(4):419-25. PubMed ID: 6710441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two forms of alpha 2-antiplasmin: post-traumatic changes in the rat.
    Högstorp H; Carlin G
    Ups J Med Sci; 1987; 92(1):79-83. PubMed ID: 2438835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 2-antiplasmin: functional characterization and metabolism in a heterozygote deficient patient.
    Knot EA; ten Cate JW; Lamping RJ; Gie LK
    Thromb Haemost; 1986 Jun; 55(3):375-8. PubMed ID: 3750266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood.
    Kluft C; Los P; Jie AF; van Hinsbergh VW; Vellenga E; Jespersen J; Henny CP
    Blood; 1986 Mar; 67(3):616-22. PubMed ID: 2418896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suitability of various plasmin preparations for the functional assay of alpha 2-antiplasmin in plasma.
    Kluft C; Traas DW; Jie AF; Hoegee-de Nobel E
    Thromb Haemost; 1982 Dec; 48(3):320-4. PubMed ID: 6219471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
    Lijnen HR; Van Hoef B; Matsuo O; Collen D
    Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
    Nilsson T; Sjöholm I; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity-chromatographic purification of human alpha 2-antiplasmin.
    Wiman B
    Biochem J; 1980 Oct; 191(1):229-32. PubMed ID: 6907016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between plasminogen and antiplasmin variants as studied by surface plasmon resonance.
    Wang H; Karlsson A; Sjöström I; Wiman B
    Biochim Biophys Acta; 2006 Nov; 1764(11):1730-4. PubMed ID: 17064970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
    Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital deficiencies in alpha 2-antiplasmin.
    Kluft C; Nieuwenhuis HK; Vellenga E
    Ric Clin Lab; 1984; 14(3):507-13. PubMed ID: 6240760
    [No Abstract]   [Full Text] [Related]  

  • 16. Mini-plasminogen like molecule in septic patients.
    Kordich LC; Porterie VP; Lago O; Bergonzelli GE; Sassetti B; Sanchez Avalos JC
    Thromb Res; 1987 Sep; 47(5):553-60. PubMed ID: 2445046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of plasminogen and antiplasmin in plasma and serum.
    Cederholm-Williams SA
    J Clin Pathol; 1981 Sep; 34(9):979-81. PubMed ID: 7276224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogen.
    Kluft C; Los P
    Thromb Haemost; 1988 Dec; 60(3):411-4. PubMed ID: 2467400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
    J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.